June 12, 2017
Alto Pharmacy finds $23M to expand across USA
ScriptDash Pharmacy has re-branded to Alto Pharmacy and raised $23M from several sources to expand to major US cities.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
June 12, 2017
Sanofi’s and Regeneron’s diabetes drug testing shows positive results
Sanofi and Regeneron Pharmaceuticals have reported positive results from two Phase 3b/4 ODYSSEY-DM trials in patients with diabetes.
June 9, 2017
IDF and Eli Lilly announce second phase of BRIDGES programme funding for translational research in diabetes
International Diabetes Federation (IDF) and Eli Lilly have come together for the second phase of the Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2), reaffirming their commitment to helping people with diabetes effectively manage their condition.
June 9, 2017
FDA approves first generic of drug for prevention of HIV and to treat HIV-1
The U.S. Food and Drug Administration has approved the first generic version of Gilead’s Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to prevent sexually-acquired HIV infection in adults at high risk.
June 9, 2017
J&J receives final EC approval to acquire Actelion
Johnson & Johnson has announced that, with today’s receipt of approval of the proposed acquisition of Actelion from the European Commission (EC), all regulatory approvals required to complete the transaction have been received.
June 9, 2017
Vertex Pharmaceuticals welcomes new independent board member
Vertex Pharmaceuticals has appointed Alan M. Garber, M.D., Ph.D. as an independent member of its board of directors.
June 7, 2017
Lyfebulb and Novo Nordisk team up again to advance entrepreneur innovation in diabetes management
Lyfebulb and Novo Nordisk have join again to support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives of people living with type 1 or type 2 diabetes – and ultimately our societies.
June 7, 2017
Allergan acquires Keller Medical, a medical device company
Allergan’s wholly-owned subsidiary, Allergan Sales LLC has acquired Keller Medical, a privately held medical device company and developer of the Keller Funnel.
June 7, 2017
Grünenthal buys AstraZeneca’s migraines drug
AstraZeneca has signed an agreement with Grünenthal for the global rights to Zomig (zolmitriptan), the drug indicated for the acute treatment of migraines and cluster headaches, outside Japan.
June 6, 2017
Celgene Corporation and Agios Pharmaceuticals report first results from acute myeloid leukemia study
Celgene Corporation and Agios Pharmaceuticals have reported new efficacy and safety data from the ongoing Phase 1 dose-escalation and expansion study evaluating investigational oral Idhifa (enasidenib) in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and an isocitrate dehydrogenase-2 (IDH2) mutation.